SRSF3 and breast carcinoma: An antisense oligonucleotide blocking an exonic splicing suppressor in the exon 4 can significantly increase inclusion of the exon 4, leading to inhibit SRSF3 expression and suppress proliferation of oral squamous cell carcinoma 172 and breast cancer cells 173.